Group 1 - The Jiangsu Data Exchange's medical service sector has officially launched and completed its first batch of on-site transactions, focusing on areas such as drug research and development, clinical diagnosis, and public health [1] - The platform facilitates safe, reliable, and efficient data services for upstream and downstream enterprises in the industry chain, with specific datasets related to gastroenteritis and lung cancer successfully traded [1] - Two medical technology companies from Hainan and Hebei have successfully acquired ten specialized medical datasets, enabling compliant cross-regional circulation of healthcare data elements [1] Group 2 - The purchasing companies faced challenges such as low data processing efficiency, inconsistent labeling standards, and difficulties in ensuring data quality, which the specialized datasets aim to address [2] - By procuring high-quality, standardized specialized disease datasets, companies can efficiently conduct AI model training and clinical research applications, significantly enhancing research efficiency and product accuracy [2] - The platform ensures data security, confidentiality, and integrity throughout the entire lifecycle of data transmission, storage, and usage, adhering to trusted data transaction protocols [2]